Notice of Award of a Sole Source Cooperative Agreement To Fund the CDC Foundation, 67942-67943 [2024-18782]

Download as PDF 67942 Federal Register / Vol. 89, No. 163 / Thursday, August 22, 2024 / Notices FTC staff assumes that the policies and procedures for compliance with the Address Discrepancy Rule will be set up by administrative support personnel at an hourly rate of $23.19 Based on the above estimates and assumptions, the total annual labor cost for the two categories of burden under section 315 is $500,181 (21,747 hours × $23). 3. Combined Annual Labor Costs Based on the foregoing, FTC staff estimates that the Red Flags, Card Issuers, and Address Discrepancy Rules will result in total annual labor costs of approximately $22,350,652 ($21,850,471 + $500,181). III. Estimated Annual Capital/NonLabor Costs: De Minimis FTC staff believes that the Rules impose negligible capital or other nonlabor costs, as the affected entities are likely to have the necessary supplies and/or equipment already (e.g., offices and computers) for the information collections described herein. ddrumheller on DSK120RN23PROD with NOTICES1 C. Request for Comment Pursuant to Section 3506(c)(2)(A) of the PRA, the FTC invites comments on: (1) whether the disclosure and recordkeeping requirements are necessary, including whether the information will be practically useful; (2) the accuracy of our burden estimates, including whether the methodology and assumptions used are valid; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information. For the FTC to consider a comment, we must receive it on or before October 21, 2024. Your comment, including your name and your state, will be placed on the public record of this proceeding, including the https:// www.regulations.gov website. You can file a comment online or on paper. Due to heightened security screening, postal mail addressed to the Commission will be subject to delay. We encourage you to submit your comments online through the https:// www.regulations.gov website. If you file your comment on paper, write ‘‘Red Flags, Card Issuers, and Address Discrepancy Rules; PRA Comment: FTC File No. P072108’’ on your comment and on the envelope, and mail it to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue 19 This estimate is based on mean hourly wage rate for office and administrative support occupations found within BLS Table 1 (see supra note 19), rounded to the nearest whole dollar amount. VerDate Sep<11>2014 17:28 Aug 21, 2024 Jkt 262001 NW, Suite CC–5610 (Annex J), Washington, DC 20580. Because your comment will become publicly available at https:// www.regulations.gov, you are solely responsible for making sure that your comment does not include any sensitive or confidential information. In particular, your comment should not include any sensitive personal information, such as your or anyone else’s Social Security number; date of birth; driver’s license number or other state identification number, or foreign country equivalent; passport number; financial account number; or credit or debit card number. You are also solely responsible for making sure that your comment does not include any sensitive health information, such as medical records or other individually identifiable health information. In addition, your comment should not include any ‘‘trade secret or any commercial or financial information which . . . is privileged or confidential’’—as provided by Section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— including, in particular, competitively sensitive information, such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. Comments containing material for which confidential treatment is requested must (1) be filed in paper form, (2) be clearly labeled ‘‘Confidential,’’ and (3) comply with FTC Rule 4.9(c). In particular, the written request for confidential treatment that accompanies the comment must include the factual and legal basis for the request and must identify the specific portions of the comment to be withheld from the public record. See FTC Rule 4.9(c). Your comment will be kept confidential only if the General Counsel grants your request in accordance with the law and the public interest. Once your comment has been posted publicly at www.regulations.gov, we cannot redact or remove your comment unless you submit a confidentiality request that meets the requirements for such treatment under FTC Rule 4.9(c), and the General Counsel grants that request. The FTC Act and other laws that the Commission administers permit the collection of public comments to consider and use in this proceeding as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before October 21, 2024. For information on the Commission’s privacy policy, including routine uses permitted by the Privacy Act, see PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 https://www.ftc.gov/site-information/ privacy-policy. Josephine Liu, Assistant General Counsel for Legal Counsel. [FR Doc. 2024–18772 Filed 8–21–24; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Award of a Sole Source Cooperative Agreement To Fund the CDC Foundation Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $17,000,000, with an expected total funding of approximately $68,000,000 over a fouryear period, to the National Foundation for the Centers for Disease Control & Prevention, Inc (CDCF). The award will use a national public health organization to strengthen the capacity of state, local and territorial public health departments to implement overdose surveillance and prevention strategies through increased staffing support and strengthen efforts to build and maintain public health/public safety partnerships. DATES: The period for this award will be September 30, 2024, through September 29, 2028. FOR FURTHER INFORMATION CONTACT: Cherie Rooks-Peck, National Center of Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Hwy., Atlanta, GA 30341 USA, Telephone: (404) 639–6429, Email: whq4@cdc.gov. SUPPLEMENTARY INFORMATION: The sole source award will use a national organization to support state, local and territorial health departments in their implementation of evidence-based overdose prevention and response activities and enhance their partnerships with public safety. Through this project, CDC will support the awardee to (1) hire, train, and support staff for positions supporting critical overdose surveillance and prevention activities; (2) build, enhance, maintain vital partnerships with public safety entities; (3) strengthen collaborations between the health SUMMARY: E:\FR\FM\22AUN1.SGM 22AUN1 Federal Register / Vol. 89, No. 163 / Thursday, August 22, 2024 / Notices department and other public health and community partners; and (4) provide technical assistance to field staff. The National Foundation for the Centers for Disease Control & Prevention, Inc (CDCF) is the only entity that can carry out this work because they have earned the trust of health departments and their partners and have been supporting them with this very need by strengthening the public health infrastructure, systems and services for overdose prevention and surveillance efforts for five years through CDC–RFA– OT18–1802. CDCF has a proven track record of successfully recruiting, training, retaining, and building capacity of the public health workforce to support overdose prevention programs such as Overdose Data to Action (OD2A) and the Overdose Response Strategy (ORS)and has established a clear process for infrastructure and capacity building needs. CDCF is widely recognized by public health entities and partners and is the only organization that was created by Congress to mobilize philanthropic and private-sector resources to support the Centers for Disease Control and Prevention’s (CDC) critical health protection work which has been critical in allowing this program to support capacity building within state, tribal, local, and territorial health departments and partnership development across all facets of public health. ddrumheller on DSK120RN23PROD with NOTICES1 Summary of the Award Recipient: National Foundation for the Centers for Disease Control & Prevention, Inc. (CDCF). Purpose of the Award: The purpose of this award is to support a national organization that will work with state, local and territorial health departments in their implementation of evidencebased overdose prevention and response activities that support OD2A in States, OD2A: LOCAL, and ORS recipients through staffing support and enhance their partnerships with public safety entities. CDCF will also provide training and technical assistance opportunities to field staff to enhance their capacity to support the implementation of evidence-based overdose prevention and response activities, and engage in various evaluation, reporting, communication, and dissemination activities to demonstrate the reach, success, and effectiveness of these capacity building activities. Amount of Award: $17,000,000 in Federal Fiscal Year (FFY) 2024 funds, with a total estimated $68,000,000 for the four-year period of performance, subject to availability of funds. VerDate Sep<11>2014 17:28 Aug 21, 2024 Jkt 262001 Authority: This program is authorized under section 392(b)(1) and (2) of the Public Health Service (PHS) Act (42 U.S.C. 280b–0(b)(1) and (2)) and section 301(a) of the PHS Act (42 U.S.C. 241(a)). Period of Performance: September 30, 2024, through September 29, 2028. Dated: August 14, 2024. Terrance Perry, Acting Director, Office of Grants Services, Centers for Disease Control and Prevention. [FR Doc. 2024–18782 Filed 8–21–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— PAR 18–812, NIOSH Member Conflict Review. Date: October 29, 2024. Time: 1 p.m.–4 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Michael Goldcamp, Ph.D., Scientific Review Officer, Office of Extramural Programs, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1095 Willowdale Road, Morgantown, West Virginia 26505. Telephone: (304) 285–5951; Email: MGoldcamp@cdc.gov. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for PO 00000 Frm 00015 Fmt 4703 Sfmt 4703 67943 both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–18857 Filed 8–21–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10767] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments on the collection(s) of information must be received by the OMB desk officer by September 23, 2024. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open SUMMARY: E:\FR\FM\22AUN1.SGM 22AUN1

Agencies

[Federal Register Volume 89, Number 163 (Thursday, August 22, 2024)]
[Notices]
[Pages 67942-67943]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18782]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Sole Source Cooperative Agreement To Fund 
the CDC Foundation

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $17,000,000, with an expected total funding of 
approximately $68,000,000 over a four-year period, to the National 
Foundation for the Centers for Disease Control & Prevention, Inc 
(CDCF). The award will use a national public health organization to 
strengthen the capacity of state, local and territorial public health 
departments to implement overdose surveillance and prevention 
strategies through increased staffing support and strengthen efforts to 
build and maintain public health/public safety partnerships.

DATES: The period for this award will be September 30, 2024, through 
September 29, 2028.

FOR FURTHER INFORMATION CONTACT: Cherie Rooks-Peck, National Center of 
Injury Prevention and Control, Centers for Disease Control and 
Prevention, 4770 Buford Hwy., Atlanta, GA 30341 USA, Telephone: (404) 
639-6429, Email: [email protected].

SUPPLEMENTARY INFORMATION: The sole source award will use a national 
organization to support state, local and territorial health departments 
in their implementation of evidence-based overdose prevention and 
response activities and enhance their partnerships with public safety. 
Through this project, CDC will support the awardee to (1) hire, train, 
and support staff for positions supporting critical overdose 
surveillance and prevention activities; (2) build, enhance, maintain 
vital partnerships with public safety entities; (3) strengthen 
collaborations between the health

[[Page 67943]]

department and other public health and community partners; and (4) 
provide technical assistance to field staff.
    The National Foundation for the Centers for Disease Control & 
Prevention, Inc (CDCF) is the only entity that can carry out this work 
because they have earned the trust of health departments and their 
partners and have been supporting them with this very need by 
strengthening the public health infrastructure, systems and services 
for overdose prevention and surveillance efforts for five years through 
CDC-RFA-OT18-1802. CDCF has a proven track record of successfully 
recruiting, training, retaining, and building capacity of the public 
health workforce to support overdose prevention programs such as 
Overdose Data to Action (OD2A) and the Overdose Response Strategy 
(ORS)and has established a clear process for infrastructure and 
capacity building needs. CDCF is widely recognized by public health 
entities and partners and is the only organization that was created by 
Congress to mobilize philanthropic and private-sector resources to 
support the Centers for Disease Control and Prevention's (CDC) critical 
health protection work which has been critical in allowing this program 
to support capacity building within state, tribal, local, and 
territorial health departments and partnership development across all 
facets of public health.

Summary of the Award

    Recipient: National Foundation for the Centers for Disease Control 
& Prevention, Inc. (CDCF).
    Purpose of the Award: The purpose of this award is to support a 
national organization that will work with state, local and territorial 
health departments in their implementation of evidence-based overdose 
prevention and response activities that support OD2A in States, OD2A: 
LOCAL, and ORS recipients through staffing support and enhance their 
partnerships with public safety entities. CDCF will also provide 
training and technical assistance opportunities to field staff to 
enhance their capacity to support the implementation of evidence-based 
overdose prevention and response activities, and engage in various 
evaluation, reporting, communication, and dissemination activities to 
demonstrate the reach, success, and effectiveness of these capacity 
building activities.
    Amount of Award: $17,000,000 in Federal Fiscal Year (FFY) 2024 
funds, with a total estimated $68,000,000 for the four-year period of 
performance, subject to availability of funds.
    Authority: This program is authorized under section 392(b)(1) and 
(2) of the Public Health Service (PHS) Act (42 U.S.C. 280b-0(b)(1) and 
(2)) and section 301(a) of the PHS Act (42 U.S.C. 241(a)).
    Period of Performance: September 30, 2024, through September 29, 
2028.

    Dated: August 14, 2024.
Terrance Perry,
Acting Director, Office of Grants Services, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-18782 Filed 8-21-24; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.